Skip to main content

To Our Valued Patients,

With the evolving situation of the Coronavirus (COVID-19) pandemic and under the guidelines of the Health Officer of the Alameda and Contra-Costa Counties, we will begin the process of re-opening our offices on Monday May 4th in order to provide needed eye and vision care. Moreover, cataract and all other non-cosmetic surgical procedures will soon resume.

Please keep in mind that in order to maintain social distancing protocols and to limit further transmission of the virus, we will be working with a reduced staff and seeing a fewer number of patients as compared to our “normal” schedule. Priority will be given to the most urgent medical cases. We will be implementing a number of measures (including altered check-in/check-out procedures, limiting the number of patients in the office and waiting room, face covering for all persons, temperature screening, etc) that will change your experience in the office. In addition, we will be ramping up our already strict disinfection policies and we will continue to monitor and abide by all local, state and, federal guidelines. Please bear with us through this new reality as these changes are designed to protect you and our staff.

We hope to see you soon and appreciate your trust in us to continue to meet your eye care needs. Stay safe and stay healthy!

The Turner Eye Institute Team






Home » What's New » Riboflavin and Corneal Crosslinking for Keratoconus

Riboflavin and Corneal Crosslinking for Keratoconus

Keratoconus patients have better opportunities than ever for treatments of their condition. Two new technologies have now been combined to offer a substantial benefit for patients with keratoconus. Corneal Collagen Crosslinking with Riboflavin combined with Intacs treatment offers an opportunity to possibly stop the deterioration of the cornea and even reverse it in many cases.

In the past, patients with keratoconus would wear hard contact lenses until those no longer helped. At that point, they would have a corneal transplant. Studies suggest however that early treatment may be beneficial in preventing this decline. Rather than wearing contact lenses until they fail, it is believed that intacs corneal inserts can be an earlier solution. Riboflavin treatment can also be used to improve the strength of the cornea.